Cybin Company Presentation

Serenity Life Sciences Inc., A wholly-owned subsidiary of Cybin Corp. has a filed patent application for the delivery of psilocybin and other psychedelics through delivery mechanisms such as sublingual strips and transdermal patches Ability to fast track drug approval targeting depression in Jamaica with pre-clinical plans already under development (1) (1) Forward-looking statements are subject to various risks and assumptions. See “Cautionary Statement Regarding Forward-Looking Information” on page 2 of this presentation. (2) Packaging is conceptual and may not adhere to requirements of applicable legislation of certain territories. Trademarks have been applied for but not registered and are subject to customary governmental approval prior to registration * Active Pharmaceutical Ingredient 11 P r i v a t e & C o n f i d e n t i a l Psychedelic Pharmaceutical Solution Science driven psilocybin based innovation Treatment oriented science focused on: 1 Dosing and bioavailability 2 Delivery mechanisms 4 5 3 API* – Synthetic, organic extraction and purification Treatment protocols and data collection (2)